Hepatobiliary and Pancreatic Surgery

Introduction

The recent development of various diagnostic techniques has led to the detection of an increasing number of borderline malignancies and benign tumors. In patients with benign or borderline malignancies, limited resection, which preserves organ function, is indicated. However, some diseases, such as invasive pancreatic cancer, gallbladder cancer, and hilar and intrahepatic cholangiocarcinoma, remain a difficult challenge for surgeons and are still associated with dismal long-term prognoses. Therefore, both medical and surgical oncology groups collectively treat hepatobiliary and pancreatic tumors as an integrated clinical activity. Thus, our treatment regimens have been developed as a result of close cooperation with medical oncologists and radiologists.

Clinical Activities

This Division includes 5 attending surgeons 3 chief residents, and 4-5 residents. The outpatient clinic is open 5 days a week. Staff meetings are held 3 times a week during which treatment strategies from the medical and surgical points of view are discussed. A case conference on imaging diagnosis is conducted every Tuesdays in cooperation with radiologists and medical oncologists, as well as a monthly pathology conference with pathologists.
In 2008, 258 patients underwent surgical treatment at our Division. In the same year, the total number of patients with liver metastasis from colorectal cancer increased (Table).

● M. Konishi ●

Table of Contents